Ginkgo BioworksDNA

紐約證券 · USD
6.56
+0.43
(+7.01%)
盤中 04/02 12:40 (UTC+8)
04/02 12:40 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.55
  • 0.35
  • 0.38
  • 0.56
  • 0.89
  • 0.44
  • 0.48
  • 0.50
  • 0.39
  • 0.33
icon
  • -31.20
  • -37.30
  • 9.18
  • 48.13
  • 58.43
  • -50.76
  • 10.20
  • 2.66
  • -21.71
  • -14.01
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
33,396
38,837
49,604
48,318
43,847
89,046
56,206
37,944
34,755
55,430
營業成本
7,30112,80214,82212,0479,62212,00313,7219,2026,6116,923
營業毛利
26,095
26,035
34,782
36,271
34,225
77,043
42,485
28,742
28,144
48,507
營業費用
96,847116,052100,323-----206,261334,900
研發費用
50,12769,35353,37070,92376,37777,006134,221136,457117,038156,662
推銷及管理費用
46,01444,95443,27949,04357,29752,29266,28570,28789,22382,028
非經常性項目費用
7061,7453,6745,2734,1572,94964,924--96,210
其他營業費用
----------
營業利益
-70,046
-90,017
-65,541
-88,968
-103,606
-55,204
-222,945
-178,002
-178,117
-286,393
其他收入及費用
-10,6429,2634,958-1,901-4,159-1,5745,95412,122-32,563-16,520
利息費用
----94---93-
稅前純益
-81,394
-80,754
-60,583
-90,869
-107,859
-56,778
-216,991
-165,880
-211,892
-302,913
所得稅
-6431-28388-325-37519031-198-22
稅後純益
-80,751
-80,755
-60,300
-90,957
-107,534
-56,403
-217,181
-165,911
-211,694
-302,891
基本每股稅後盈餘(元)
-1.41-1.45-1.10-1.68-2.00-1.08-0.11-0.08--0.16
稀釋每股稅後盈餘(元)
-1.42-1.45-1.09-1.68-1.96-1.02-0.11-0.08-0.11-0.15
基本平均股數(千股)
57098.0055633.0054858.0054241.0053814.0052240.002054801.002004458.00-1950800.00
稀釋平均股數(千股)
57098.0055633.0054858.0054241.0053814.0052246.002055023.002005334.00-1950800.00
還原基本每股稅後盈餘(元)
-1.41-1.45-1.10-1.68-2.00-1.08-4.23-3.31--6.21
還原稀釋每股稅後盈餘(元)
-1.42-1.45-1.09-1.68-1.96-1.02-4.24-3.32-4.28-6.09
還原基本平均股數(千股)
57,09855,63354,85854,24153,81452,24051,37050,111-48,770
還原稀釋平均股數(千股)
57,09855,63354,85854,24153,81452,24651,37550,133-48,770
EBITDA(千元)
-68,619-69,088-44,790-75,503-92,113-39,609-199,661-153,011-197,915-281,853

大家都在看

HOT